Clinical Research Directory
Browse clinical research sites, groups, and studies.
INfluenza VaccInation To Mitigate typE 1 Diabetes
Sponsor: Aarhus University Hospital
Summary
In a multicenter, prospective, randomized, controlled clinical trial to compare influenza vaccination and placebo in sustaining β cell function in early type 1 diabetes mellitus.
Official title: INfluenza VaccInation To Mitigate typE 1 Diabetes (INVITED Trial)
Key Details
Gender
All
Age Range
7 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2022-12-14
Completion Date
2027-05-01
Last Updated
2025-05-22
Healthy Volunteers
No
Conditions
Interventions
Vaxigrip Tetra Sanofi Pasteur Europe
We will use 0.5 mL standard dose quadrivalent influenza vaccine containing 15 μg of hemagglutinin per strain consistent with WHO recommendations according to season.
Locations (10)
Aalborg University Hospital
Aalborg, Denmark
Aarhus University Hospital
Aarhus, Denmark
Steno Diabetes Center Copenhagen
Copenhagen, Denmark
Gødstrup Hospital
Herning, Denmark
Holbaek Sygehus
Holbæk, Denmark
Nykoebing F Sygehus
Nykøbing Falster, Denmark
Randers Regional Hospital
Randers, Denmark
Sjællands Universitetssygehus
Roskilde, Denmark
Slagelse Hospital
Slagelse, Denmark
Viborg Regional Hospital
Viborg, Denmark